Common diabetes drug linked to lower rate of long COVID Metformin is the most common type 2 diabetes drug prescribed to millions of American each year, and a new study from researchers at the National Institutes of Health (NIH) published in Diabetes Care suggests the drug can lower the risk of developing long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC), in diabetics. CIDRAP

...

Metformin lowers blood sugar and is most commonly prescribed as a first-line treatment for type 2 diabetes. The drug also is prescribed off-label for weight loss and other metabolic conditions.

...

Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic

COVID-19 epidemiological update – 17 September 2024 Edition 171

...

Globally, during the 28-day period (22 July to 18 August 2024), the number of new cases and deaths increased by 23% and 44% compared to the previous 28-day period (24 June to 18 August 2024), with 238 000 new cases reported across 91 (39%) countries and about 4400 new fatalities reported across 35 (15%) countries, respectively. As of 22 July to 18 August 2024, over 776 million confirmed cases and more than seven million deaths have been reported globally since the beginning of pandemic.

Machine-learning monoclonal antibody allocation in pandemic could cut hospital cases by a third If drugs and medical treatments are in short supply during a pandemic, a new model shows how machine learning can help decide how to distribute medicines and reduce hospitalizations by up to 27%. CIDRAP

...